Search
JNJ-55308942
go.drugbank.com/drugs/DB19110InvestigationalJNJ-55308942 is under investigation in clinical trial NCT05328297 (A Study of JNJ-55308942 in the Treatment of Bipolar Depression).
Categories: Purinergic P2 Receptor Antagonists, Purinergic P2X Receptor AntagonistsMecapegfilgrastim
go.drugbank.com/drugs/DB19147InvestigationalMecapegfilgrastim is under investigation in clinical trial NCT05463601 (Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer).
Atexakin alfa
go.drugbank.com/drugs/DB19234InvestigationalAtexakin alfa is under investigation in clinical trial NCT05435742 (SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN)).
Orellanine
go.drugbank.com/drugs/DB19263InvestigationalOrellanine is under investigation in clinical trial NCT05287945 (Study of Orellanine in Metastatic Clear-cell or Papillary Renal Cell Carcinoma).
GI-181771X
go.drugbank.com/drugs/DB12309ExperimentalGski181771 X is under investigation in clinical trial NCT00600743 (Effect of a CCK-1R Agonist on Food Intake in Humans).
Categories: Receptor, Cholecystokinin A, agonistsFilociclovir
go.drugbank.com/drugs/DB12438InvestigationalFilociclovir is under investigation in clinical trial NCT01433835 (Safety and Pharmacokinetics of Single Oral Doses of Filociclovir in Healthy Volunteers).
Lenrispodun
go.drugbank.com/drugs/DB15039InvestigationalITI-214 is under investigation in clinical trial NCT03489772 (Study of ITI-214 in Healthy Volunteers to Determine CNS Engagement).
Pemafibrate
go.drugbank.com/drugs/DB15212InvestigationalPemafibrate is under investigation in clinical trial NCT03350165 (A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)).
Synonyms: K-877Gedivumab
go.drugbank.com/drugs/DB15277InvestigationalGedivumab is under investigation in clinical trial NCT01877785 (A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy Volunteers).
Gimsilumab
go.drugbank.com/drugs/DB15280InvestigationalGimsilumab is under investigation in clinical trial NCT01357759 (Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects).